J B Hunt Transport Services Inc vs Nuwellis Inc — how do they compare? J B Hunt Transport Services Inc trades at $230 (market cap $20.91B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: J B Hunt Transport Services Inc is far larger — about 9504.5× Nuwellis Inc's market cap, and J B Hunt Transport Services Inc pays a 0.81% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold J B Hunt Transport Services Inc for 45 Days and Nuwellis Inc for 26 Days on average.
| JBHT | NUWE | |
|---|---|---|
Market Cap | $20.91B | $2.20M |
Volume | 684,242 | 121,544 |
Sector | Industrials | Health |
52-Week High | $298.41 | $146.65 |
52-Week Low | $137.09 | $0.68 |
Typical Hold Time | 45 Days | 26 Days |
Enterprise Value | $22.05B | -$1.52M |
Dividend Yield | 0.81% | — |
Signals from Pluang's Aura AI — not financial advice
JBHT trades at $228.42, up 1.1% with bearish technical signals but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending. Revenue stabilized at $12B in 2025 after previous declines, while profitability improved with 5.31% net margin. Analyst consensus remains strongly bullish with $287.53 price target despite ongoing securities investigations creating headline risk.
The stock presents a divergence between bearish technical indicators and positive fundamental trajectory. Upside potential exists from earnings momentum and industry tailwinds, but risks include legal investigations and cost pressures. Wall Street's 58.7% buy rating suggests confidence in long-term value despite near-term volatility from legal overhangs and fuel cost challenges.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →